At the defense
Andreas Benn with the members of his committee

Andreas Benn is the first BSIO student to defend his thesis - congratulations!

Andreas Benn is the first BSIO student who finished his project work and successfully defended his thesis that had been supervised by Prof. Petra Knaus (FU Berlin) and Prof. Thorsten Cramer (RWTH Aachen), further committee members were Prof. Oliver Daumke (MDC Berlin), Prof. Dr. Sigmar Stricker (MPI for Molecular Genetics, FU Berlin) and Dr. Chris Weise (FU Berlin). Congratulations!

Invitation: Jan 6, 4.30 p.m.: BSIO Female Independency Award and MKFZ Recognition Award Symposium

We would like to cordially invite you to the Award Symposium of the Berlin School of Integrative Oncology - Female Independency Award and the  MKFZ Recognition Award

When? Wednesday, 06 January, 2016 at 4.30 p.m

Where? Charité Berlin, CVK, Forum 4, Pathology Lecture Hall

The BSIO Award aims to support female researchers working in the field of cancer research who intent to start their own research group and has therefore been established to support women in science, especially during the transition phase from postdoc to group leader. The awardees of the Award symposium of the Berlin School of Integrative Oncology - Female Independency Award are:

Dr. Il-Kang Na - Concurrent visualization of trafficking, expansion, and activation of adoptively transferred T cells

as well as

Dr. Michaela Serresi - Molecular mechanisms underlying lung cancer dissemination to the brain

The MKFZ Recognition Award has been established for young Charité cancer researchers who will present their projects that have been published in high-ranked journals in 2015. The awardee of the MKFZ Recognition Award is:

Lynn Jeanette Savic - Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer

 

*The symposium will be followed by a dinner reception at the foyer of the research building Forum 4.

Award symposium of the BSIO Female Independency Award and the MKFZ Rising Star awards on December 11, 2014

On December 11, 2014, the award symposium of the Berlin School of Integrative Oncology (BSIO) Female Independency Award (FIA) as well as the Molecular Cancer Research Center (MKFZ) Rising Star-Award took place.

During the symposium, the awardees of both awards presented their work and discussed its implications and open questions lively with the audience.

The Female Independency Award is awarded annually by the graduate school “Berlin School of Integrative Oncology” which is DFG-funded in the framework of the German excellence initiative. It supports outstanding female scientists who are either aiming to start their own group soon or who have recently become group leader in the field of cancer research and thus aims to facilitate the critical transition phase to independency for female scientists and therefore to increase the number of female group leaders in cancer research.

With many highly competitive applications having been submitted for the award, the decision has been challenging. Finally, two awardees have been selected and share the Female Independency Award support that includes a (in this case shared) flexible grand of 50.000 €, coaching and mentoring opportunities and the inclusion into the junior faculty of the graduate school: Dr. Michela di Virgilio and Dr. Hedwig Deubzer.

Dr. di Virgilio, who has been a postdoc in the lab of Michael Nussenzweig at Rockefeller University New York/USA before becoming a junior group leader at the Max-Delbrück-Center (MDC) in fall 2014, focuses on “Deregulation of DNA end processing and it role in carcinogenesis”. While Dr. di Virgilio is a basic scientist by training, the second awardee, Dr. Hedwig Deubzer, is a physician scientist in the field of pediatric oncology and divides her time between research and clinic. She also came to Berlin quite recently and works in the department of Prof. Angelika Eggert, head of the Charité Center 17 for Pediatric and Adolescent Medicine. Her research focuses on “Epigenetic Modifications in Neuroblastoma – Novel Therapeutic Targets”.

Not only have the awardees of the Female Independency Award presented their work and scientific visions for the future at the symposium, but the awardees of the Rising Star Award of the Charité’s Molecular Cancer Research Center (MKFZ) have also presented their recently published work to the broad audience of the symposium. The award is endowed with 1000 € and is given to young scientists (doctoral candidates and postdocs up to 35 years of age) who have published their results as first authors in high-ranked papers in the past 12 months. This has been accomplished by Dr. Frederik Damm, Dr. Mareike Frick and André Weilemann, being the 2014 awardees.

Dr. Frederik Damm has published his work entitled “Acquired initiating mutations in early hematopoietic cells of CLL patients” in Cancer Discovery. The second awardee, Dr. Mareike Frick, has been selected for the award for having published her work on “Pharmacological and genomic profiling identifies NF‐κB‐targeted treatment strategies for mantle cell lymphoma” in Nature Genetics. Last but not least, the doctoral candidate André Weilemann, who is working in the group of Prof. Georg Lenz, has published his work on “Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma” in the journal Blood.

Congratulations to all awardees of the BSIO Female Independency Award and the Rising Star Awards of the Molecular Cancer Research Center (MKFZ), we hope to see more of their work in the future!


The BSIO Female Independency Award symposium on December 11, 2014 at 4.30 p.m.!

We would like to announce the awardees of the 2014 the Berlin School of Integrative Oncology (BSIO) Female Independency Awards, they are

Dr. Michela di Virgilio and

Dr. Hedwig Deubzer.

Congratulations!

The “BSIO Female Independency Award” - the award symposium will take place on December 11 at 4.30 p.m. at Forum 4, Campus Virchow-Klinikum, the symposium will also feature talks of the Rising Star awardees of the Molecular Cancer Research Center (MKFZ); the symposium will be followed by a dinner reception at Forum 4.

All interested colleagues and guests are cordially invited to join the symposium!

 

A campus map can be found here

New Call for "Clinical Scientist" Positions - Applications are accepted until August 15, 2014

Applications in the framework of the current call  for "Clinical Scientist" positions are accepted until August 15.

Research active clinicians at the Charité from their third specialization year on are encouraged to apply. 

Please refer to http://intranet.charite.de/service/stellenangebote/?tx_list_pi1%5Buid%5D=2120&tx_list_pi1%5Bmode%5D=10&cHash=576cf8de10e1c07ab48c618062b55894 for further information (Charité intranet site). 

2014 Application round for Phd and MD students

The deadline for the current application round was July 1, so the application tool is currently closed.

The next application round will take place in summer 2015, with the deadline being July 1.

An overview of the current BSIO students can be found at http://www.bsio-cancerschool.de/?id=93.

 


Talk by Dr. Thomas Joos on August 5, 2014 at 4. p.m., CVK

Dr. Thomas Joos from theUniversity of Tübingen will give a talk on “Immunoassays in Multiplex for Biomarker Discovery and Validation” in the framework of the BSIO Speaker Series on August 5 at 4 p.m. at the Pathology lecture hall, Campus Virchow-Klinikum (Seestrasse 5, internal campus address Forum 4).

After the talk, there will be a little reception at the foyer of Forum 4.

Everyone interested is cordially invited to join the talk!

Talk by Prof. Christian Buske on October 25, 2013 at 3. p.m.

Prof. Christian Buske from Ulm University will give a talk on "Early developmental genes in the biology of acute myeloid leukemia?" in the framework of the BSIO Speaker Series on October 25 at 3 p.m. at the Pathology lecture hall, Forum 4, Virchow-Klinikum, CVK).

Prof. Buske is one of the leading experts in the fields of Functional characterization of genetic alterations in acute leukemias, Non-coding RNAs in the pathobiology of acute leukemias and identification of cancer stem cells.

After the talk, there will be a little reception at the foyer. Everyone interested is cordially invited to join the talk!

Talk by Prof. Robert H. Shoemaker on November 19, 2013 at 2. p.m.

Prof. Bob Shoemaker from the National Cancer Institute, Frederick, USA  will give a talk on "Real-Time Kinetic Analysis of the In Vitro Invasion Phenotypes of the NCI60 Tumor Cell Line Panel Enables Identification of Genes Associated with Mesenchymal Invasion and Inhibitory Compounds" in the framework of the BSIO Speaker Series on November 19 at 2 p.m. at the MDC Communications Building MDC.C, Axon II, Campus Buch (Robert-Rössle-Strasse 10, 13125 Berlin).

After the talk, there will be a little reception at the MDC.C. Everyone interested is cordially invited to join the talk!

New BSIO doctoral students will start their work in fall 2013.

The BSIO just finishes its 2013 selection round. The doctoral students accepted in the current round will start their work in fall 2013.

Female Independency Award 2013 awarded to Dr. Angela Relogio

In the framework of the Award symposium of the Berlin School of Integrative Oncology - Female Independency Award (FIA) on December 18 at 4 p.m., Dr. Angela Relogio received the FIA for outstanding female cancer researcher at the transition phase of founding her own research group.

Dr. Angela Relogio works on "Oncogene-mediated deregulation of the circadian clock in cancer".